Du F, Wang W, Wang Y, Li M, et al. Carboplatin plus taxanes are non-inferior to epirubicin plus cyclophosphamide followed by taxanes as adjuvant chemotherapy for early triple-negative breast cancer. Breast Cancer Res Treat 2020 May 11. pii: 10.1007/s10549-020-05648.
PMID: 32394350